Birth before or after 40 weeks raises cerebral palsy risk

Article

Infants delivered at 37 or 38 weeks' gestation or at 42 weeks or later are at increased risk for cerebral palsy compared with those delivered at 40 weeks, according to new study findings.

Infants delivered at 37 or 38 weeks' gestation or at 42 weeks or later are at increased risk for cerebral palsy compared with those delivered at 40 weeks, according to the findings of a recent study from Norway.

Researchers analyzed data from a national birth registry and the national health insurance system on more than 1.6 million singleton children born without congenital anomalies between 1967 and 2001 at a gestational age of 37 through 44 weeks. Of the cohort, 1,938 had cerebral palsy.

The lowest risk for cerebral palsy was found in infants born at 40 weeks (prevalence of 0.99 per 1,000; 95% CI, 0.90-1.08). Prevalence at 37 weeks was 1.91 per 1,000 (95% CI, 1.58-2.25) with a relative risk (RR) of 1.9 (95% CI, 1.6-2.4) and at 38 weeks was 1.25 per 1,000 (95% CI, 1.07-1.42) with a RR of 1.3 (95% CI, 1.1-1.6). Prevalence at 42 weeks was 1.36 per 1,000 (95% CI, 1.19-1.53) with a RR of 1.4 (95% CI, 1.2-1.6) and after 42 weeks was 1.44 per 1,000 (95% CI, 1.15-1.72) with a RR of 1.4 (95% CI, 1.1-1.8).

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.